Novo Nordisk President & CEO Mike Doustdar discusses the recent US approval of Novo Nordisk's Wegovy weight loss pill, the advantage of being the first to market, the availability of the pill, the company's gameplan, and the timeline of the pill's release. Doustdar spoke with Bloomberg's Katie Greifeld.

Canada's Foreign Affairs Minister Anita Anand Talks Trade Tensions, China
06:48

Spanish Prime Minister Pedro Sanchez Talks ECB Succession
08:34

Microsoft President Brad Smith Talks Investing in the Gulf
14:54